Glaucoma surgery is a rapidly evolving therapy that has demonstrated substantial benefit yet has fallen short of offering an effective means for the management of all glaucoma patients. Our proprietary Calibreye™ Titratable Glaucoma Therapyä (TGT) Surgical System aims to provide next-generation IOP management, safety without sacrificing efficacy, a familiar delivery technique, and the ability to adjust flow to meet the individual treatment needs of patients.
The Calibreye TGT System offers physicians unprecedented control with the ability to selectively titrate outflow (up or down) in a simple office visit. The system is implanted with a standard ab externo delivery technique similar to that used in trabs/tube shunts. The product design has been completed using materials with long histories of use in the eye and manufactured using microtechnology precision.
If accepted, the company presentation will review the Calibreye TGT System, its principal of operation, the clinical procedures and techniques, and early clinical results including IOP, glaucoma medications, procedural success, and safety.